Extract from the report on clinical studies PCC X-1
Clinical studies were carried out PCC X-1
The study group included 12 patients aged from 21 to 58 years with diseases of the stomach and intestines.
PCC X-1 was prescribed against the background of complex therapy of patients in a recommended dosage for 12 days.
At the end of the course of treatment with the use of the product, pain completely disappeared in 76% of patients, unstable recurrent pains in the epigastrium and left hypochondrium remained in 14%. Heartburn, nausea significantly decreased in 35% and completely disappeared in 65% of patients.
In 74% of patients, bowel movements returned to normal, decreased, and then completely disappeared bloating and discomfort after eating. Complete epithelialization of ulcers, according to endoscopy, occurred in 3 of 5 patients in whom a duodenal ulcer was diagnosed, incomplete in 2 patients.
In the course of clinical studies of PCC X-1 there were no side effects. All patients noted that the product was well tolerated. Conclusion: PCC X-1 is an effective food supplement in the prevention and treatment of diseases of the gastrointestinal tract. PCC X-1 has an anti-ulcer and restorative effect on the mucous membrane of the stomach and duodenum. Scarring of ulcerative defects in the duodenal bulb in patients with peptic ulcer disease and the disappearance of erosive and inflammatory lesions of the mucous membrane in acute pancreatitis and cholecystitis were noted. The cytoprotective effect of the product on increasing mucus in the epithelial cells of the mucous membrane was noted.
PCC X-1 is characterized by good tolerance and the absence of adverse reactions in patients. The results of clinical studies make it possible to recommend the use of PCC X-1 as an additive to the diet in the treatment and prevention of diseases of the gastrointestinal tract.
Research on the use of PCC X-1 in acute pancreatitis
New studies were carried out on the use of PCC X-1 in acute pancreatitis. Over the past thirty years, there has been more than a twofold increase in the number of chronic and acute inflammations of the pancreas (pancreatitis).
This was the main reason for new research on the use of the dietary supplement PCC X-1 ,which contains polyphenolic compounds of natural origin and can be used in diseases of the pancreas. Early research on PCC X-1 confirmed that melanins (polyphenolic compounds) from the black yeast Nadsoniella nigra var. possess radio- and photoprotective, antitumor, immunomodulatory, hepatoprotective, antitoxic and antioxidant properties.
In new experimental studies, the classical model of stress by G. Selye was used. The experiment involved three control groups, stress resistance of which was determined using the neuroethological test “Open Field”. In conditions of prolonged chronic stress, the body’s reserves are depleted, and the ability to adapt decreases. The main mechanisms of the damaging effect of stress syndrome on cells is the activation of free-radical oxidation, which promotes lipid peroxidation of cell membranes and oxidative modification of proteins. As a result of this process, endogenous intoxication of the body develops, a universal indicator of which is an increase in the level of active α-amylase and lipase, which leads to the development of acute pancreatitis.
As a result of research “The protective effect of melanin on the pancreas under stress syndrome” it was proved that there was a decrease in the activity of alpha-amylase and lipase in the three control groups by 1.3 times. This confirms the beneficial effects of melanin on the pancreas. In addition, as a result of the research, other positive properties of melanins were revealed: an increase in the production of nitric oxide, a powerful vasodilator (vasodilator), which improves microcirculation and tissue nutrition, and as a result, the processes of tissue regeneration (restoration) are accelerated.
As a result of the experiment, the high efficiency of the product PCC X-1 and its positive effect on the pancreas in conditions of acute pancreatitis were proved.